Active pharmaceutical ingredient (API)

WHO define this term as “a substance used in a finished pharmaceutical product (FPP), intended to furnish pharmacological activity or to otherwise have direct in the diagnosis, cure, mitigation, treatment or prevention of disease, or to have direct effect in restoring, correcting or modifying physiological functions in human beings.”

Indian API Market:

Indian market considers as growing API market with thirteenth position among the largest pharmaceutical industries in the world. Indian API Market growing due to advancements in API manufacturing and the development of the biopharmaceutical division. as of now in 2023 data about 670 USFDA approved plant in India. About 57 percent of APIs on the World Health Organization’s prequalified list come from the Indian region.

Top 10 API manufacturer in India:

Aurobindo Pharma

Sun Pharmaceutical Industries Ltd.

Cipla Ltd.

Lupin Pharmaceuticals:

Zydus Cadila

Hetero Drugs

Biocon Ltd.

Mylan Laboratories

Dr. Reddy’s Laboratories

Divis Labs